Sigma's Imprint(TM) Methylated DNA Quantification Kit significantly simplifies the study of Global Methylation with results in half the time of
ST. LOUIS, Oct. 30 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today introduced its Imprint(TM) Methylated DNA Quantification Kit (MDQ1) for epigenetic research http://www.sigma-aldrich.com/mdq1. The Methylated DNA Quantification Kit employs a familiar ELISA-like procedure, with no radioactivity or chromatography, to measure global methylation in less than four hours. The kits are effective with a DNA input as low as 5ng of fully methylated DNA and are arranged in a flexible 8-well assay strips format, allowing for high-throughput applications or manual analysis of DNA from cultured cells, tissues, plasma and other body fluid samples. Imprint MDQ technology will enable scientists to rapidly quantify the global methylation status of biological samples, providing insight into conditions that alter methylation status and facilitating advanced disease research.
The introduction of MDQ1 kits provides researchers with an alternative to currently available methods for quantifying global methylation, such as reverse phase HPLC, MALDI-TOF-MS, methylation sensitive restriction fingerprinting, DNA methyltransferase assays, immunohistostaining, and dot blots. MDQ1 kits include all necessary reagents, enabling laboratories to screen samples in-house rather than sending them to core facilities.
"Our Imprint Methylated DNA Quantification Kits offer complete and
rapid solutions for the quantification of global DNA methylation," said Tim
Fleming, Director of Commercial Marketing at Sigma-Aldrich. "The addition
of this exciting technology to our epigenetic research product suite
reflects Sigma- Aldrich's commitment to developing a robust platform of
technologies to support the epigenetics researc
Copyright©2008 PR Newswire.
All rights reserved